Prelude Therapeutics Incorporated
SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5)

Last updated:

Abstract:

The disclosure is directed to compounds of Formula I ##STR00001## Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.

Status:
Application
Type:

Utility

Filling date:

17 Feb 2022

Issue date:

9 Jun 2022